Paper Details

  1. Home
  2. Paper Details

Review of placebo-controlled trials with bupropion.

Author: ZungW W

Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.
Clinical TrialA clinical trial is a planned study conducted on humans to evaluate the efficacy and safety of pharmaceuticals, medical devices, and treatment methods. It aims to explore the possibilities of new treatments and improve the health of patients.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.

Overview

Bupropion was more effective than placebo in treating depression and anxiety in four multicenter studies. About 60-70% of patients responded to bupropion compared to 30% with placebo. Effects were seen within 5 days to 3 weeks. Bupropion had a side effect profile similar to placebo and no significant cardiovascular or lab changes were observed.
Paper Details　
Original Abstract of the Article :
Results of four multicenter randomized double-blind placebo-controlled studies of the antidepressant efficacy and safety of bupropion are reviewed. Bupropion was superior to placebo on the Hamilton Depression and Anxiety Rating Scales, Clinical Global Impressions-Improvement, and patient self-rating...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://pubmed.ncbi.nlm.nih.gov/6406436

データ提供：米国国立医学図書館（NLM）

Bupropion: A Promising Oasis in the Desert of Depression

Depression, a condition that often feels like a vast and unforgiving desert, can leave people feeling lost and hopeless. This study explores the effectiveness of bupropion, an antidepressant, in treating depression. The researchers conducted a series of randomized double-blind placebo-controlled studies to compare the effects of bupropion to a placebo. Their findings suggest that bupropion is an effective antidepressant with an excellent side effect profile.

Bupropion's Effectiveness: A Beacon of Hope in the Desert

The study found that bupropion was significantly more effective than placebo in reducing depressive symptoms. The proportion of patients responding to bupropion was typically 60%-70%, compared to approximately 30% for placebo. This difference, like finding a clear path through a confusing desert, is a significant improvement for patients struggling with depression. The study also found that bupropion's side effects were similar to those of placebo, making it a relatively well-tolerated treatment option. It's like finding a oasis with gentle breezes and refreshing water – a welcome reprieve from the harsh desert environment.

Navigating the Desert of Depression: Bupropion Offers a Path Forward

The study provides encouraging evidence for the effectiveness of bupropion as an antidepressant. If you are struggling with depression, it's important to discuss treatment options with your healthcare professional. Bupropion could be a valuable tool in helping you navigate the desert of depression and find your way to a brighter future. Remember, you're not alone in this journey. There are resources and support available to help you find your way.

Dr.Camel's Conclusion

Bupropion, like a beacon of hope in the vast desert of depression, appears to be an effective treatment option with minimal side effects. The study provides encouraging evidence for its effectiveness, but it's crucial to work with a healthcare professional to determine the best course of action for your individual needs. Together, you can navigate the challenges of depression and find your way to a brighter future.

Date :
  1. Date Completed 1983-07-08
  2. Date Revised 2013-11-21
Further Info :

Pubmed ID

6406436

DOI: Digital Object Identifier

6406436

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.